Binding of pCRP to human monocytes was assessed by flow cytometry with conformation specific antibodies for pCRP (anti-pCRP-8D8) and a FITC labeled secondary antibody. EDTA significantly reduced binding of pCRP to activated monocytes, indicating a specific, Ca 2+ -dependent interaction. Displayed are mean values and the SEM (n=5). p-values were calculated with a paired t-test. (D) Representative confocal fluorescence microscopy pictures (3D reconstruction) of human monocytes. Cells were treated as in (C). The nuclei were stained with DAPI (blue), pCRP with anti-pCRP-8D8 and a FITC labeled secondary antibody (green). Scale bars depict 10 µm. (E) Binding of pCRP to LPS-activated human monocytes was analysed by flow cytometry. Cells were treated as in (C), however, indicated amounts of purified human IgG were added, which binds to human Fcγ receptors. Neither 5 µg/ml nor 50 µg/ml of purified human IgG had an influence on the LPS induced pCRP-cell interaction. (F) LPSactivated human monocytes were incubated with increasing concentrations of pCRP and analysed by flow cytometry as described under (C THP-1 There is a clear difference in the accessibility of the tryptophan residues to the charged quencher iodide when comparing pCRP and mCRP (A). Shown is a representative graph from n=3 independent experiments. The lower KSV for mCRP suggests that the quenching agent is more easily able to interact with and hence quench the fluorescence of the tryptophan residues as compared to pCRP. Freshly prepared pCRP and pCRP + liposome samples, however, appear to be effectively identical in their accessibility to quenching by iodide. Published data suggests that the formation of a pCRP-liposome complex takes some time, with fluorescence data indicating a stable state is not formed for around 2 hours 1 . Allowing this process to proceed by incubating the samples overnight shows that pCRP remains unchanged, but the pCRP-liposome complex that forms has altered the accessibility of the tryptophan residues in the protein as indicated by a non-linear Stern-Volmer plot (B). A modified Stern-Volmer plot (C) indicates that ~25% of the tryptophan fluorescence is easily accessible to iodide with the remaining residues protected. Fig. 9C ) in pCRP and mCRP. CRP isoforms were incubated with DTT. The reaction was stopped with NEM and the proteins separated on oxidizing SDS-PAGE. CRP was detected with anti-CRP-8 antibodies after Western blot. Consistent with previous reports, we did not observe reduction of the intra-subunit disulfide bond in pCRP, whereas it was efficiently reduced in mCRP. (B) To exclude the possibility that components within the tissue lysate inhibited the detection of mCRP, control mCRP was spiked into lysates of healthy skin. We observed efficient reduction under these conditions, indicating that mCRP can reliably be detected in tissue lysates by this assay. Experiments were conducted as described above. (C) As mCRP has a tendency to aggregate under physiological buffer conditions we also investigated whether mCRP is lost during clearing of tissue lysates by centrifugation. Tissue was lysed according to our standard protocol and the crude extract was then analyzed without further centrifugation. Again, we observed only minimal reduction of tissue deposited CRP in our assay. Samples were treated as in (B), however, the tissue lysate was not cleared by centrifugation when indicated (crude lysate). Signal intensity was continuously measured from the microvesicle area and a control area without microvesicles thus recording binding events in real-time. Initially, fast association of Alexa488-C1q to the reference area (5% BSA) was observed in the presence of pCRP, which probably reflects the ability of pCRP to bind to albumin. This was followed by a steady increase in the fluorescence signal, which reflects binding to the microvesicle-covered area. Binding kinetics are similar to the association of CMFDA labeled microvesicles to immobilized C1q (Fig. 6 A) . Shaded areas represent SEM (n=3). (B) Gating strategy to determine C3 deposition on microvesicles by flow cytometry. CMFDA labeled THP-1 microvesicles (positive in FITC channel) were incubated with normal human sera (NHS) after pre-incubation with pCRP or mCRP. Deposited C3 and its cleavage products were stained with antibodies directed against C3c, iC3b (neoepitope specific), C3d and a second APC labeled antibody. The percentage of C3 positive microvesicles was determined by calculating Q2/(Q2 + Q4). Q3 depicts unlabeled microvesicles and background due to "instrument noise". pCRP led to increased deposition of complement C3 components. The structural integrity of commercial pCRP was determined by assessing its ability to bind to PC/LPC liposomes. The interaction of pCRP with liposomes was Ca 2+ -dependent, suggesting a specific interaction between pCRP and exposed phosphocholine head groups of the PC/LPC liposomes. (C) Purified microvesicles (P 16,000 g) were analyzed by flow cytometry. Microvesicles were highly pure and the majority of particles had a size < 1.1 µm. 
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